Multiple myeloma patients experience high response rate with new 3-drug combination
Sunday, December 6, 2009 - 12:28
in Health & Medicine
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow.